About
ABOUT US
SERVICESWho We Are
DEIRA LIMITED is a pharmaceutical development and manufacturing company specializing in Active Pharmaceutical Ingredients (APIs), analytical testing, clinical research support, and pharmaceutical supply chain solutions.
Bringing a pharmaceutical compound from laboratory discovery to commercial production involves significant scientific, regulatory, and operational challenges. DEIRA LIMITED supports pharmaceutical innovators throughout this process by delivering high-quality analytical testing, clinical research support, API sourcing, manufacturing coordination, and regulatory documentation services.
Our technical expertise spans recombinant DNA technologies, chemical synthesis and analysis, fermentation, chromatography, and botanical extraction. We provide access to a diverse portfolio of APIs supported by integrated technical capabilities and comprehensive Drug Master File (DMF) documentation suitable for research, development, formulation, and commercial manufacturing activities.
Leveraging a strategically positioned network of laboratories and clinical research facilities across Europe, the Middle East, and Asia-Pacific, DEIRA LIMITED delivers harmonized solutions to pharmaceutical and biotechnology organizations. Our specialists provide analytical development, biologics characterization, biosafety testing, quality control services, and clinical research support from early-stage Phase I studies through Phase III clinical programs.
Our products originate from carefully selected API manufacturing partners located throughout the Middle East and Asia and are supported by internationally recognized quality and regulatory frameworks.
We believe that accelerating access to innovative medicines improves lives worldwide. DEIRA LIMITED is committed to transforming pharmaceutical supply chains through integrated, end-to-end solutions that help pharmaceutical and biopharmaceutical companies bring products to market efficiently, safely, and compliantly.
As part of our long-term international growth strategy, DEIRA LIMITED continues to evaluate opportunities for expansion into key European pharmaceutical markets and the establishment of additional operational capabilities to support future growth.
Our products originate from carefully selected API manufacturing partners located throughout the Middle East and Asia and are supported by internationally recognized quality and regulatory frameworks.
We believe that accelerating access to innovative medicines improves lives worldwide. DEIRA LIMITED is committed to transforming pharmaceutical supply chains through integrated, end-to-end solutions that help pharmaceutical and biopharmaceutical companies bring products to market efficiently, safely, and compliantly.
As part of our long-term international growth strategy, DEIRA LIMITED continues to evaluate opportunities for expansion into key European pharmaceutical markets and the establishment of additional operational capabilities to support future growth.
"Our leadership position is founded on scientific excellence, operational integrity, and a commitment to innovation. Through advanced manufacturing partnerships, specialized pharmaceutical expertise, and highly experienced professionals, DEIRA LIMITED delivers dependable quality, regulatory compliance, and technical solutions that support the evolving needs of the global pharmaceutical industry."
Subscribe to our newsletter
Subscribe to our newsletter
© 2026 DEIRA LIMITED. All rights reserved.
RC 018845V
Registered in the Isle of Man
German